Thomas Soloway

Thomas Soloway

Direktör/Styrelseledamot på THIRD HARMONIC BIO, INC.
59 år
Health Technology
Consumer Services
Finance

Profil

Thomas M.
Soloway
was the founder of Transcept Pharma, Inc. (2002) and served as SVP, Chief Operating & Financial Officer from 2012 to 2013.
Current jobs include Chief Executive Officer at T-Knife GmbH since 2021, President & Chief Executive Officer at T-Knife Therapeutics, Inc., and Independent Director at Third Harmonic Bio, Inc. since 2022.
Former jobs include Director at Novacea, Inc. in 2009, Independent Director at Satsuma Pharmaceuticals, Inc. from 2020 to 2023, Principal at Montreux Equity Partners, Inc. from 1993 to 2002, Senior Vice President-Media at Ascendis Pharma A from 2015 to 2019, Chief Financial Officer, Treasurer & Senior VP at Astellas Gene Therapies, Inc. in 2020, and Chief Operating Officer at Paratek Pharmaceuticals, Inc. Education includes an undergraduate degree from the University of Southern California and an MBA from Georgetown University.

Aktiva positioner av Thomas Soloway

FöretagPositionStart
THIRD HARMONIC BIO, INC. Direktör/Styrelseledamot 2022-07-01
Verkställande Direktör 2021-01-19
Verkställande Direktör -

Tidigare kända positioner av Thomas Soloway

FöretagPositionSlut
SATSUMA PHARMACEUTICALS, INC. Direktör/Styrelseledamot 2023-06-08
AUDENTES THERAPEUTICS, INC. Finansdirektör/CFO 2020-09-01
ASCENDIS PHARMA A/S Finansdirektör/CFO 2015-09-01
Grundare 2013-12-01
Direktör/Styrelseledamot 2009-02-06
Se detaljerna i Thomas Soloways erfarenhet

Thomas Soloways utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

54

Första gradens relationer

12

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag12

Consumer Services

Finance

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Thomas Soloway
- 40% : De bästa verktygen för abonnenter som vill hitta morgondagens bästa investeringar!
d
:
:
TA FÖRDEL AV DET NU